These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 9192977)
1. Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas. Eder IE; Stenzl A; Hobisch A; Cronauer MV; Bartsch G; Klocker H Br J Cancer; 1997; 75(12):1753-60. PubMed ID: 9192977 [TBL] [Abstract][Full Text] [Related]
2. Reduced expression of TGF beta is associated with advanced disease in transitional cell carcinoma. Coombs LM; Pigott DA; Eydmann ME; Proctor AJ; Knowles MA Br J Cancer; 1993 Mar; 67(3):578-84. PubMed ID: 8439507 [TBL] [Abstract][Full Text] [Related]
3. Expression of transforming growth factor beta1 and its receptors in normal human urothelium and human transitional cell carcinomas. Izadifar V; de Boer WI; Muscatelli-Groux B; Maillé P; van der Kwast TH; Chopin DK Hum Pathol; 1999 Apr; 30(4):372-7. PubMed ID: 10208456 [TBL] [Abstract][Full Text] [Related]
4. p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours. Le Frère-Belda MA; Cappellen D; Daher A; Gil-Diez-de-Medina S; Besse F; Abbou CC; Thiery JP; Zafrani ES; Chopin DK; Radvanyi F Br J Cancer; 2001 Nov; 85(10):1515-21. PubMed ID: 11720438 [TBL] [Abstract][Full Text] [Related]
5. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder. Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of TGF-beta1 and TGF-beta3 in serosal tissues of human intraperitoneal organs and peritoneal adhesions. Chegini N; Kotseos K; Zhao Y; Bennett B; McLean FW; Diamond MP; Holmdahl L; Burns J Hum Reprod; 2001 Jun; 16(6):1291-300. PubMed ID: 11387308 [TBL] [Abstract][Full Text] [Related]
7. Expression of transforming growth factor-beta 1 in human bladder cancer. Miyamoto H; Kubota Y; Shuin T; Torigoe S; Dobashi Y; Hosaka M Cancer; 1995 May; 75(10):2565-70. PubMed ID: 7736402 [TBL] [Abstract][Full Text] [Related]
8. [Effects of silencing Smad ubiquitination regulatory factor 2 on the function of human hypertrophic scar-derived fibroblasts]. Zhang Z; Kuang F; Liu CL; Chen B; Tang WB; Li XJ Zhonghua Shao Shang Za Zhi; 2017 Mar; 33(3):145-151. PubMed ID: 28316163 [No Abstract] [Full Text] [Related]
9. Differential expression of and responsiveness to transforming growth factor-beta (TGF-beta) isoforms in hormone-dependent and independent lines of mouse mammary tumors. Viegas MH; Salatino M; Goin M; Peters G; Labriola L; Costa da cunha J; Lanari C; Charreau EH; Elizalde PV Cancer Detect Prev; 1999; 23(5):375-86. PubMed ID: 10468889 [TBL] [Abstract][Full Text] [Related]
10. Micro-array analysis of the effect of post-transurethral bladder tumor resection urine on transforming growth factor-beta1 dependent gene expression in transitional cell carcinoma. Zhang G; Cao Y; Xu Y; See WA Urol Oncol; 2005; 23(6):413-8. PubMed ID: 16301119 [TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone. Masi L; Malentacchi C; Campanacci D; Franchi A Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923 [TBL] [Abstract][Full Text] [Related]
13. Desensitization of melanoma cells to autocrine TGF-beta isoforms. Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-4- and interleukin-13-enhanced transforming growth factor-beta2 production in cultured human bronchial epithelial cells is attenuated by interferon-gamma. Wen FQ; Kohyama T; Liu X; Zhu YK; Wang H; Kim HJ; Kobayashi T; Abe S; Spurzem JR; Rennard SI Am J Respir Cell Mol Biol; 2002 Apr; 26(4):484-90. PubMed ID: 11919085 [TBL] [Abstract][Full Text] [Related]
15. Molecular insights on the effect of TGF-β1/-β3 in human corneal fibroblasts. Guo X; Hutcheon AEK; Zieske JD Exp Eye Res; 2016 May; 146():233-241. PubMed ID: 26992778 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of transforming growth factor-β1 suppress Pokemon/epithelial-mesenchymal transition expression in human bladder cancer cells. Li W; Kidiyoor A; Hu Y; Guo C; Liu M; Yao X; Zhang Y; Peng B; Zheng J Tumour Biol; 2015 Feb; 36(2):1155-62. PubMed ID: 25722217 [TBL] [Abstract][Full Text] [Related]
17. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures. De Groot CJ; Montagne L; Barten AD; Sminia P; Van Der Valk P J Neuropathol Exp Neurol; 1999 Feb; 58(2):174-87. PubMed ID: 10029100 [TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid. Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line. Okamoto M; Oyasu R Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis. Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]